Ousted from her position as director of the Centers for Disease Control and Prevention less than a month after her confirmation, Susan Monarez has now had the chance to tell her side of the story before Congress.
At a two-day meeting, the Center for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted 8-3 to change the current recommendations that allow children under age 4 to receive the MMRV vaccine, a combination shot for measles, mumps, rubella and chickenpox (or varicella).
The American Association for Cancer Research released the results of a national survey measuring voters’ attitudes about federal funding for medical research, which found very high levels of support for federal funding for medical and cancer research across the electorate.
FDA has begun to crack down on direct-to-consumer prescription drug advertising.
A panel of doctors and lawmakers launched the bipartisan Stem Cell Therapeutic and Research Reauthorization Act of 2025 (HR 5160) and discussed its positive impacts on research, healthcare, and treatment in the United States.
A fraught Senate Finance Committee hearing, where HHS Secretary Robert F. Kennedy Jr. clashed with Republicans and Democrats alike, has led to some fallout.
The Trump administration earlier this week released its strategy on children’s health.
Vinay Prasad has regained his role as FDA’s chief medical and scientific officer, according to an update on the agency’s website.
FDA introduced the Rare Disease Evidence Principles to provide greater speed and predictability in the review of therapies intended to treat rare diseases with very small patient populations with significant unmet medical need and that are driven by a known genetic defect.
The U.S. House Appropriations Committee has voted along party lines passing a bill that maintains current funding levels for NIH and NCI as part of its Fiscal Year 2026 Labor, HHS, Education and Related Agencies spending bill.
